466
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Multimodal Evaluation of Patients with Acute Posterior Multifocal Placoid Pigment Epitheliopathy and Serpiginous Choroiditis

, MD, , MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 1212-1218 | Received 04 Feb 2017, Accepted 24 May 2017, Published online: 29 Sep 2017

References

  • Crawford CM, Igboeli O. A review of the inflammatory chorioretinopathies: The white dot syndromes. ISRN Inflamm. 2013;2013:783190.
  • Herbort CP, Mantovani A, Papadia M. Use of indocyanine green angiography in uveitis. Int Ophthalmol Clin. 2012;52:13–31.
  • Spaide RF, Goldberg N, Freund KB. Redefining multifocal choroiditis and panuveitis and punctate inner choroidopathy through multimodal imaging. Retina. 2013;33:1315–1324.
  • Bansal R, Gupta A, Gupta V. Imaging in the diagnosis and management of serpiginous choroiditis. Int Ophthalmol Clin. 2012;52:229–236.
  • Novais EA, Baumal CR, Sarraf D, et al. Multimodal imaging in retinal disease: A consensus definition. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar:47(3). doi:10.3928/23258160-20160229-01. PMID: 26985792.
  • Combillet F, Rougier MB, Blaizeau M, et al. “Em face” optical coherence tomograph for multiple evanescente white dot syndrome. Journal Français D’ophthalmologie. 2013 Oct:36(8):652–657.
  • Baumal CR, De Carlo TE, Nadia BA, et al. Sequential optical coherence tomographic angiography for diagnosis and treatment of choroidal neovascularization in multifocal choroiditis. JAMA Ophthalmol. 2015 Sep:133(9):1087–1090.
  • Ha SO, Kim DY, Sohn CH, et al. Anaphylaxis caused by intravenous fluorescein: clinical characteristics and review of literature. Intern Emerg Med. 2014;9(3):325–330.
  • Shanshan Y, Jing L, Cao D, et al. The role of optical coherence tomography angiography in fundus vascular abnormalities. BMC Ophalmology. 2016;16:107.
  • De Carlo TE, Bonini Filho MA, Chin AT, et al. Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology. 2015;122:1228–1238.
  • Liang MC, De Carlo TE, Baumal CR, et al. Correlation of spectral domain optical coherence tomography angiography and clinical activity in neovascular age-related macular degeneration. Retina. 2016 Dec:36(12):2265–2273.
  • Mandali SKR, Agarwal A, Aggarwal K, et al. Novel finding on optical coherence tomography angiography in patients with tubercular serpinginous-like choroiditis. Retina. 2016;0:1–13.
  • Agarwal A, Kanika Aggarwal MS, Mbbs AD, et al. Optical coherence tomography angiography features of paradoxical worsening in tubercular multifocal serpiginoid choroiditis. Ocul Immunol Inflamm. 2016;00(00):1–10.
  • Gupta A, Biswas J. Fundus autofluorescence imaging to document evolution, progression and healing pattern of serpiginous choroiditis. Oman J Ophthalmol. 2014 May-Aug;7(2):100–101.
  • Malamos P, Masaoutis P, Georgalas I, et al. The role of fundus autofluorescence imaging in the study of the course of posterior uveitis disorders. Biomed, Res Int. 2015;2015:247469. doi:10.1155/2015/2474617.
  • Mrejen S, Sarraf D, Chexal S, et al. Choroidal involvement in acute posterior multifocalplacoid pigment epitheliopathy. Ophthalmic Surg Lasers Imaging Retina. 2016;47.1(1):20.
  • Kuehlewein L, Bansai M, Lentis TL, et al. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol. 2015 Oct:160(4):739–48.e2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.